HEALTH AND SAFETY

» Drug, Devices, and Supplements

» Physician Accountability

» Consumer Product Safety

» Worker Safety

» Health Care Delivery

» Auto and Truck Safety

» Global Access to Medicines

» Infant Formula Marketing

 

Commentary in The New York Times “Room for Debate” Series on Trying Newly Approved Medications

November 18, 2013

In an invited commentary as part of The New York Times’ “Room for Debate" series, Public Citizen answers the question, “How do you know whom to trust?” when it comes to drug safety. Dr. Sidney Wolfe urges patients to determine whether the maker of a drug paid for its research and to seek independent advice. Wolfe also advocates following the "seven-year rule," which advises patients not to take a new drug for at least seven years from the drug’s release date (except in cases of rare "breakthrough" drugs with known advantages over older drugs).

The complete commentary can be viewed at: http://www.nytimes.com/roomfordebate/2013/11/17/when-medical-experts-disagree/dont-rush-to-try-new-medication

Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.

Public Citizen lobbies Congress and federal agencies to advance Public Citizen’s mission of advancing government and corporate accountability. When you make a contribution to Public Citizen, you become a member of Public Citizen, showing your support and entitling you to benefits such as Public Citizen News. Contributions to Public Citizen are not tax-deductible.

Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.